Serial #79182121
LIVE

Serial Number

79182121

Owner

CODAN HOLDING GMBH

Attorney

Joseph A. Sebolt

Filing Date

Dec 2, 2015

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79182121 Trademark

Serial Number: 79182121 • Registration: 5288117

Serial #79182121 is a trademark filed by CODAN HOLDING GMBH on December 2, 2015. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CODAN HOLDING GMBH (23 trademarks)

Lensahn 23738 , DE

Entity Type: 16

CODAN Medizinische Geräte GmbH (13 trademarks)

Stig Husted-Andersen Straße 11

Entity Type: 99

Trademark Details

Filing Date

December 2, 2015

Registration Date

September 19, 2017

Published for Opposition

July 4, 2017

Goods & Services

Medical apparatus and instruments for infusion, transfusion, drawing blood, measuring blood pressure, providing enteral and oral nutrition, and for surgical procedures in the fields of urology, incontinence, neonatology and pediatrics; Medical apparatus and instruments, namely, infusion sets, transfusion sets, extension tube lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, catheters, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, special sets for preparation and administration of total intravenous anesthesia (TIVA) with said sets being comprised primarily of syringes sold empty, syringe pumps, medical valves for controlling the flow of fluids through infusion tubes, infusion lines and manifold connections for the delivery of fluids for medical purposes, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, infusion spikes in the nature of specialized needles for intravenous infusion, intravenous (I.V.) filters and/or filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, special sets for preparation and administration of cytotoxic drugs, with said sets being comprised primarily of extension tube lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubes, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, cannulas, syringes sold empty, protective clothing for medical purposes, namely, coveralls, gowns, hoods, face masks, filter masks, gloves, safety glasses, [ overshoes ] for protection against accidents with cytotoxic drugs, bags and containers for disposing of contaminated cleaning materials and spilled hazardous drugs, workplace covers used on table and counter surfaces to absorb spills during the preparation of cytotoxic drugs, medical tubing extensions for enteral and oral nutrition, disposable syringes sold empty, invasive blood pressure monitoring systems, urology administration and irrigation sets, infusion pumps, syringe pumps, withdrawal sets for withdrawal of blood comprised primarily of [ burettes, ] extension tube lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, medical tubing for the withdrawal of blood, syringes sold empty, cannulas, preparation sets for preparation of drugs comprised primarily of extension lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles of intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluid, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, cannulas, syringes sold empty, [ protective gloves for medical purposes, protective gowns for medical purposes, bags and containers for disposing of contaminated cleaning materials and spilled hazardous drugs, workplace covers used on table and counter surfaces to absorb spills during the preparation of drugs, ] administration sets for administration of drugs and liquids, with said sets being comprised primarily of burettes, extension lines and manifold connectors for the delivery of fluid for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, medical tubing for the withdrawal of blood, syringes sold empty, and cannulas * ; * [ , workplace covers used on table and counter surfaces to absorb spills during the preparation of drugs, spill sets for safe removal of hazardous drugs comprised primarily of barriers to restrict access to contaminated areas, caution tape, containers for disposing of contaminated cleaning materials and spilled hazardous drugs, cleaning material for removing hazardous drugs, protective clothing for medical purposes, namely, coveralls, gowns, hoods, face masks, filter masks, gloves, safety glasses, overshoes for protection against accidents with hazardous drugs, bags and containers for contaminated items, cleaning material, spilled hazardous drugs, and workplace covers for covering medical workplaces for protection against accidents with hazardous drugs; ] parts and fittings of all the aforesaid goods [ ; protective clothing for medical purposes, namely, coveralls, gowns, hoods, face masks, filter masks, gloves, safety glasses, overshoes for protection against accidents with cytotoxic drugs ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jan 1, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jan 1, 2025 C75A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Dec 20, 2024 EROP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 8, 2024 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 16, 2024 INPR
PROOF OF USE INTERIM ACTION ISSUED
Jun 28, 2024 PUMI
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 29, 2024 EROP
PROOF OF USE INTERIM ACTION ISSUED
Mar 15, 2024 PUMI
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Mar 11, 2024 EROP
OFFICE ACTION ISSUED POU1
Sep 12, 2023 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 10, 2023 APRE
TEAS SECTION 71 & 15 RECEIVED
Sep 8, 2023 ES75
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 13, 2023 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 19, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 26, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 30, 2017 FICS
FINAL DISPOSITION PROCESSED
Dec 30, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 19, 2017 FICR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 20, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 20, 2017 REAP
REGISTERED-PRINCIPAL REGISTER
Sep 19, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 4, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jul 4, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Jul 1, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 14, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 14, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 24, 2017 CNSA
NEW REPRESENTATIVE AT IB RECEIVED
Mar 16, 2017 NREP
ATTORNEY REVIEW COMPLETED
Jan 20, 2017 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jan 18, 2017 CREV
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 18, 2017 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 9, 2016 CRCV
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2016 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 29, 2016 ERFR
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 25, 2016 CRCV
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 4, 2016 TCCA
FINAL REFUSAL MAILED
Oct 18, 2016 CNFR
FINAL REFUSAL WRITTEN
Oct 17, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2016 TROA
REFUSAL PROCESSED BY IB
May 13, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 22, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 20, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 12, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 11, 2016 REPR